Anesthetics can spur brain plaque

A class of widely used anesthetics spurs production of beta amyloid in the brains of mice, according to a study completed at the University of Pennsylvania. Researchers studied halothane, one in a class of volatile anesthetics used on 60 million people a year. A common side effect of these anesthetics is 'post-operative cognitive decline' that can last from days to years. If the drugs also promote beta amyloid in the brains of humans, it could provide a direct link to Alzheimer's. While there is no conclusive proof that beta amyloid causes Alzheimer's, the presence of brain plaque is a common feature of the disease. Researchers in the field have been pushing an array of drug development programs that target beta amyloid.

- here's the report on the study from Nature

Suggested Articles

Compass' CD137 agonist cleared large tumors in mice that other I-O agents had failed to treat. It's advancing the drug into phase 1 human trials.

UPMC researchers are planning clinical trials of a COVID-19 vaccine that uses pieces of the virus' spike protein to create immunity.

Treating mice with niacin increased the number of immune cells in glioblastomas, reducing tumor size and extending survival.